CRISPR-A, organoids and autism: searching for a potential preventative


BioTechniques News
Maddy Chapman

Using CRISPR activation (CRISPR-A) methods in a mix of neuronal cell cultures and brain organoids, researchers may have found two targets for early developmental interventions to inhibit the development of autism spectrum disorder (ASD).

Recent research from the University of California, Los Angeles (CA, USA) has utilized CRISPR-A methods in neural-organoid and neuronal cell models to investigate the potential of a novel approach for treating ASD. Finding that their approach, which amplified the expression of two high-confidence ASD risk genes, was successful in restoring key aspects of function in both models, the team is confident that it has therapeutic potential for ASD.

While ASD is highly heritable, between 15-20% of the genetic risk comes from de novo mutations that result in haploinsufficiency, the harmfully low expression of a gene product when one gene of the allele pair is dysfunctional. Of the many genes identified as vulnerable to these ASD-associated de novo mutations, CHD8 and SCN2A are among the most well-categorized and high-confidence, leading the authors to select them as targets for further study.

CHD8 is thought to regulate many other ASD risk genes involved in synaptic function and neurodevelopment, and its expression peaks during neurogenesis. SCN2A encodes a voltage-gated sodium channel responsible for the generation and propagation of action potentials and is expressed, predominantly in the brain, later than CHD8, beginning in mid-fetal development.

The team selected human pluripotent stem cell-derived excitatory neurons and cerebral forebrain organoids as models in which to interrogate the role of these two genes, turning to CRISPR-A as the tool with which to modulate their expression. CRISPR-A has at times been shown to be slightly overzealous when directed to gene promoters, leading to excessive gene expression and incapacitation of cells. As CHD8 and SCN2A mutations typically lead to haploinsufficiency and not full knockout of gene expression, the team were keen to avoid this hazard of CRISPR-A and instead chose to target gene enhancers.


May I have your attention, please: ancient neurons hold ADHD clues

Researchers have discovered neurons in a highly conserved vertebrate brain region that play a significant role in directing attention.


Using this approach, they found that in the CHD8 models, enhancer-targeted CRISPR-A (eCRISPR-A) brought gene activity closer to typical levels, helping cells to mature normally and, in the organoid models, reducing aberrant organoid overgrowth. Meanwhile, in the SCN2A models, eCRISPR-A was able to largely restore the neurons’ normal electrical activity, but some finer aspects of this activity remained incapacitated in some cell lines. What’s more, these increases in gene expression were only observed in mutant models; healthy cells remained unchanged.

Commenting on the significance of this last point, study first author George Chen explained that what stood out for them was “that the approach acted only in cell lines carrying the mutation and left healthy cell lines alone. That kind of specificity matters for any future therapy. We are still a long way from the clinic, and there is a lot of work ahead on delivery and timing, but these findings provide hope and give us a clear direction.”

While George highlights the limitations and the work yet to be done, the timing of administration for any potential intervention resulting from these findings would make it an exceptionally advanced therapeutic. The timing of administration mattered, with interventions for CHD8 administered at 25 days into organoid development and SCN2A at 100. While these organoids are significantly different to a developing live brain, a rough translation would mean that a direct clinical intervention would need to be administered before most pregnancies are typically confirmed. The core value of this increase in our understanding of the condition remains, though, with significant potential impact for prenatal screens, genetic counseling and more.

The post CRISPR-A, organoids and autism: searching for a potential preventative appeared first on BioTechniques.

Powered by WPeMatico

Full BioTechniques Article here

Leave a Reply